MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$256,000
-24.7%
126,849
+1.0%
0.00%
Q4 2021$340,000
-40.5%
125,547
-2.0%
0.00%
Q3 2021$571,000
-24.2%
128,088
-1.3%
0.00%
Q2 2021$753,000
-16.6%
129,769
+0.9%
0.00%
Q1 2021$903,000
+30.7%
128,656
-10.6%
0.00%
Q4 2020$691,000
-18.4%
143,903
-1.0%
0.00%
Q3 2020$847,000145,3470.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders